Amneal Pharmaceuticals, Inc. (AMRX) announced on Wednesday that it has received FDA approval for its Over the Counter Naloxone Hydrochloride or HCI Nasal Spray, USP, 4mg.
This nasal spray is designed to quickly counteract the effects of a life-threatening opioid emergency by interacting with opioid receptors to reverse or block opioid effects.
Manufactured in the U.S., Amneal's Naloxone HCI Nasal Spray is a generic version of the widely used OTC NARCAN HCI Nasal Spray.
Amneal's Naloxone HCI Nasal Spray is now accessible over the counter.
For comments and feedback contact: editorial@rttnews.com
Business News
December 12, 2025 15:14 ET Central bank decisions dominated the economic news flow this week led by the Federal Reserve. Trade data from the U.S. also gained attention. The Canadian and Swiss central banks also announced their interest rate decisions. Inflation data from China was in focus as the country released the latest consumer price and producer price data.